419 related articles for article (PubMed ID: 21633248)
1. Atrial fibrillation and atrial fibrosis.
Tan AY; Zimetbaum P
J Cardiovasc Pharmacol; 2011 Jun; 57(6):625-9. PubMed ID: 21633248
[TBL] [Abstract][Full Text] [Related]
2. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.
Burstein B; Nattel S
J Am Coll Cardiol; 2008 Feb; 51(8):802-9. PubMed ID: 18294563
[TBL] [Abstract][Full Text] [Related]
3. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
Savelieva I; Kakouros N; Kourliouros A; Camm AJ
Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
[TBL] [Abstract][Full Text] [Related]
4. Atrial structural remodeling as an antiarrhythmic target.
Burstein B; Nattel S
J Cardiovasc Pharmacol; 2008 Jul; 52(1):4-10. PubMed ID: 18594481
[TBL] [Abstract][Full Text] [Related]
5. Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications.
Lau YF; Yiu KH; Siu CW; Tse HF
J Hum Hypertens; 2012 Oct; 26(10):563-9. PubMed ID: 22129612
[TBL] [Abstract][Full Text] [Related]
6. [New approach for atrial fibrillation by suppression of renin-angiotensin system].
Kumagai K
Nihon Rinsho; 2005 Mar; 63(3):523-7. PubMed ID: 15773355
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation and renin-angiotensin system.
Serra JL; Bendersky M
Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
[TBL] [Abstract][Full Text] [Related]
8. Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation.
Ducharme A; Schiffrin EL
Can J Cardiol; 2010 Dec; 26 Suppl E():21E-23E. PubMed ID: 21620287
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the renin-angiotensin system for prevention of atrial fibrillation.
Zografos T; Katritsis DG
Pacing Clin Electrophysiol; 2010 Oct; 33(10):1270-85. PubMed ID: 20636314
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in atrial fibrillation.
Levine MJ; Schweitzer P
Vnitr Lek; 2010 Nov; 56(11):1138-41. PubMed ID: 21247007
[TBL] [Abstract][Full Text] [Related]
11. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
12. [The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences of atrial fibrillation].
Doğan A; Akçay S
Anadolu Kardiyol Derg; 2009 Dec; 9(6):505-11. PubMed ID: 19965325
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrosis and the mechanisms of atrial fibrillation.
Everett TH; Olgin JE
Heart Rhythm; 2007 Mar; 4(3 Suppl):S24-7. PubMed ID: 17336879
[TBL] [Abstract][Full Text] [Related]
14. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.
Healey JS; Morillo CA; Connolly SJ
Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation.
De Jong AM; Maass AH; Oberdorf-Maass SU; Van Veldhuisen DJ; Van Gilst WH; Van Gelder IC
Cardiovasc Res; 2011 Mar; 89(4):754-65. PubMed ID: 21075756
[TBL] [Abstract][Full Text] [Related]
16. Current concepts in the pathogenesis of atrial fibrillation.
Kourliouros A; Savelieva I; Kiotsekoglou A; Jahangiri M; Camm J
Am Heart J; 2009 Feb; 157(2):243-52. PubMed ID: 19185630
[TBL] [Abstract][Full Text] [Related]
17. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
Lévy S
Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):220-5. PubMed ID: 16568131
[TBL] [Abstract][Full Text] [Related]
18. ACE-inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation.
Boldt A; Scholl A; Garbade J; Resetar ME; Mohr FW; Gummert JF; Dhein S
Basic Res Cardiol; 2006 May; 101(3):261-7. PubMed ID: 16382287
[TBL] [Abstract][Full Text] [Related]
19. [Unsatisfactory results of upstream therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for the prevention of recurrent atrial fibrillation].
Disertori M; Zeni P; Quintarelli S; Bonmassari R
G Ital Cardiol (Rome); 2010 Nov; 11(11):829-34. PubMed ID: 21348320
[TBL] [Abstract][Full Text] [Related]
20. The renin-angiotensin system: a therapeutic target in atrial fibrillation.
Patlolla V; Alsheikh-Ali AA; Al-Ahmad AM
Pacing Clin Electrophysiol; 2006 Sep; 29(9):1006-12. PubMed ID: 16981926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
